Novartis AG
IMMUNE-ENHANCING RNAS FOR COMBINATION WITH CHIMERIC ANTIGEN RECEPTOR THERAPY
Last updated:
Abstract:
The invention provides compositions and methods for treating diseases such as cancer. The invention also relates to a method of administering a chimeric antigen receptor (CAR) therapy and an additional therapeutic agent.
Status:
Application
Type:
Utility
Filling date:
8 Jan 2019
Issue date:
26 Nov 2020